Jessica Davis-Knowlton

Jessica Davis-Knowlton

Auto-generated profile, based on publicly available information

Jessica Davis-Knowlton

Center for Molecular Medicine, MaineHealth Institute for Research, MaineHealth, Scarborough, Maine, USA

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 February 2019 in Journal of Tissue Engineering and Regenerative Medicine
Verified
Journal Article
Closed access
PDF file
AGAshwani Kumar Gupta
Ashwani Kumar Gupta
JCJeannine M. Coburn
Jeannine M. Coburn
JDJessica Davis‐Knowlton
Jessica Davis‐Knowlton
EKErica Kimmerling
Erica Kimmerling
DKDavid Kaplan
David Kaplan
LOLeif Oxburgh
Leif Oxburgh

1 March 2012 in Journal of Insect Physiology
Verified
Journal Article
Closed access
GGGraham Ganter
Graham Ganter
JDJ.B. Desilets
J.B. Desilets
JDJ.A. Davis-Knowlton
J.A. Davis-Knowlton
APA.E. Panaitiu
A.E. Panaitiu
MSM. Sweezy
M. Sweezy
RHR. Heinrich
R. Heinrich

23 May 2018 in Laboratory Investigation
Verified
Journal Article
Closed access
PDF file
JDJessica Davis-Knowlton
Jessica Davis-Knowlton
JTJacqueline E. Turner
Jacqueline E. Turner
ATAnna Turner
Anna Turner
SDSydney Damian-Loring
Sydney Damian-Loring
NHNicholas Hagler
Nicholas Hagler
LLLucy Liaw
Lucy Liaw

1 July 2018 in Arteriosclerosis, Thrombosis, and Vascular Biology
Verified
Journal Article
Closed access
PDF file
SPSarah M. Peterson
Sarah M. Peterson
JTJacqueline E. Turner
Jacqueline E. Turner
AHAnne Harrington
Anne Harrington
JDJessica Davis-Knowlton
Jessica Davis-Knowlton
VLVolkhard Lindner
Volkhard Lindner
LLLucy Liaw
Lucy Liaw
Objective— Vascular remodeling is associated with complex molecular changes, including increased Notch2, which promotes quiescence in human smooth muscle cells. We used unbiased protein profiling to understand molecular signatures related to neointimal lesion formation in the presence or absence of Notch2 and to test the hypothesis that loss of Notch2 would increase neointimal lesion formation because of a hyperproliferative injury response. Approach and Results— Murine carotid arteries isolated at 6 or 14 days after ligation injury were analyzed by mass spectrometry using a data-independent acquisition strategy in comparison to uninjured or sham injured arteries. We used a tamoxifen-inducible, cell-specific Cre recombinase strain to delete the Notch2 gene in smooth muscle cells. Vessel morphometric analysis and immunohistochemical staining were used to characterize lesion formation, assess vascular smooth muscle cell proliferation, and validate proteomic findings. Loss of Notch2 in smooth muscle cells leads to protein profile changes in the vessel wall during remodeling but does not alter overall lesion morphology or cell proliferation. Loss of smooth muscle Notch2 also decreases the expression of enhancer of rudimentary homolog, plectin, and annexin A2 in vascular remodeling. Conclusions— We identified unique protein signatures that represent temporal changes in the vessel wall during neointimal lesion formation in the presence and absence of Notch2. Overall lesion formation was not affected with loss of smooth muscle Notch2, suggesting compensatory pathways. We also validated the regulation of known injury- or Notch-related targets identified in other vascular contexts, providing additional insight into conserved pathways involved in vascular remodeling. Download figure Download PowerPoint

7 July 2022 in Journal of Vascular Research
Verified
Journal Article
Closed access
PDF file
JDJessica Davis-Knowlton
Jessica Davis-Knowlton
JTJacqueline E. Turner
Jacqueline E. Turner
AHAnne Harrington
Anne Harrington
LLLucy Liaw
Lucy Liaw
Introduction: We previously identified Notch2 in smooth muscle cells (SMC) in human atherosclerosis and found that signaling via Notch2 suppressed human SMC proliferation. Thus, we tested whether loss of Notch2 in SMC would alter atherosclerotic plaque progression using a mouse model. Methods: Atherogenesis was examined at the brachiocephalic artery and aortic root in a vascular SMC null (inducible smooth muscle myosin heavy chain Cre) Notch2 strain on the ApoE−/− background. We measured plaque morphology and size, as well as lipid, inflammation, and smooth muscle actin content after Western diet. Results: We generated an inducible SMC Notch2 null on the ApoE−/− background. We observed ∼90% recombination efficiency with no detectable Notch2 in the SMC. Loss of SMC Notch2 did not significantly change plaque size, lipid content, necrotic core, or medial area. However, loss of SMC Notch2 reduced the contractile SMC in brachiocephalic artery lesions and increased inflammatory content in aortic root lesions after 6 weeks of Western diet. These changes were not present with loss of SMC Notch2 after 14 weeks of Western diet. Conclusions: Our data show that loss of SMC Notch2 does not significantly reduce atherosclerotic lesion formation, although in early stages of plaque formation there are changes in SMC and inflammation.